ClinicalTrials.gov
public full text
Public Domain
Reducing Risk of Dementia Through Deprescribing
A cluster-randomized controlled trial (RCT) called "Reducing Risk of Dementia through Deprescribing" (R2D2) to evaluate the impact of a deprescribing intervention on important cognitive and safety outcomes.
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- The Efficacy of Cognitive Remediation in Depression: A Systematic Literature Review and Meta-Analysis#1054824
- Data-driven Approaches to Healthcare Provider Resilience & Burnout During COVID-19#842283
- Methodology of analysis of cognitive impairment in longitudinal randomized clinical trials in oncology: a scoping review.#615644
- Effects of Remotely Delivered and Web-Based Interventions on Depression Severity During the COVID-19 Pandemic: 3-Arm Randomized Controlled Trial.#430696
- Prenatal Education About Reducing Labor Stress (PEARLS)#917936
Record · ID 1229859
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive